Literature DB >> 9012400

Gene regulation by mRNA editing.

J Ashkenas.   

Abstract

Mesh：

Substances：

Year:  1997        PMID： 9012400      PMCID： PMC1712409     

Source DB:  PubMed          Journal:  Am J Hum Genet        ISSN： 0002-9297            Impact factor:   11.025


× No keyword cloud information.
  41 in total

1.  RNA editing in brain controls a determinant of ion flow in glutamate-gated channels.

Authors:  B Sommer; M Köhler; R Sprengel; P H Seeburg
Journal:  Cell       Date:  1991-10-04       Impact factor: 41.582

2.  Apolipoprotein B mRNA editing. Direct determination of the edited base and occurrence in non-apolipoprotein B-producing cell lines.

Authors:  K Boström; Z Garcia; K S Poksay; D F Johnson; A J Lusis; T L Innerarity
Journal:  J Biol Chem       Date:  1990-12-25       Impact factor: 5.157

3.  Molecular genetic analysis of tumors in von Recklinghausen neurofibromatosis: loss of heterozygosity for chromosome 17.

Authors:  G R Skuse; B A Kosciolek; P T Rowley
Journal:  Genes Chromosomes Cancer       Date:  1989-09       Impact factor: 5.006

4.  Glutamate receptor RNA editing in vitro by enzymatic conversion of adenosine to inosine.

Authors:  S M Rueter; C M Burns; S A Coode; P Mookherjee; R B Emeson
Journal:  Science       Date:  1995-03-10       Impact factor: 47.728

5.  Ontogenetic regulation of apolipoprotein B mRNA editing during human and rat development in vivo.

Authors:  A P Patterson; G E Tennyson; J M Hoeg; D D Sviridov; H B Brewer
Journal:  Arterioscler Thromb       Date:  1992-04

6.  A novel form of tissue-specific RNA processing produces apolipoprotein-B48 in intestine.

Authors:  L M Powell; S C Wallis; R J Pease; Y H Edwards; T J Knott; J Scott
Journal:  Cell       Date:  1987-09-11       Impact factor: 41.582

7.  Apolipoprotein B mRNA editing is an intranuclear event that occurs posttranscriptionally coincident with splicing and polyadenylation.

Authors:  P P Lau; W J Xiong; H J Zhu; S H Chen; L Chan
Journal:  J Biol Chem       Date:  1991-10-25       Impact factor: 5.157

8.  Apolipoprotein B-48 is the product of a messenger RNA with an organ-specific in-frame stop codon.

Authors:  S H Chen; G Habib; C Y Yang; Z W Gu; B R Lee; S A Weng; S R Silberman; S J Cai; J P Deslypere; M Rosseneu
Journal:  Science       Date:  1987-10-16       Impact factor: 47.728

9.  Elimination of apolipoprotein B48 formation in rat hepatoma cell lines transfected with mutant human apolipoprotein B cDNA constructs.

Authors:  Z M Yao; B D Blackhart; D F Johnson; S M Taylor; K W Haubold; B J McCarthy
Journal:  J Biol Chem       Date:  1992-01-15       Impact factor: 5.157

10.  Human apolipoprotein B (apoB) mRNA: identification of two distinct apoB mRNAs, an mRNA with the apoB-100 sequence and an apoB mRNA containing a premature in-frame translational stop codon, in both liver and intestine.

Authors:  K Higuchi; A V Hospattankar; S W Law; N Meglin; J Cortright; H B Brewer
Journal:  Proc Natl Acad Sci U S A       Date:  1988-03       Impact factor: 11.205
View more
  3 in total

Review 1.  Biological significance of RNA editing in cells.

Authors:  Wei Tang; Yongjun Fei; Michael Page
Journal:  Mol Biotechnol       Date:  2012-09       Impact factor: 2.695

Review 2.  Message therapy: gene therapy that targets mRNA sequence and stability.

Authors:  K F Kozarsky; L A Couture
Journal:  Am J Hum Genet       Date:  1997-10       Impact factor: 11.025

3.  C-->U editing of neurofibromatosis 1 mRNA occurs in tumors that express both the type II transcript and apobec-1, the catalytic subunit of the apolipoprotein B mRNA-editing enzyme.

Authors:  Debnath Mukhopadhyay; Shrikant Anant; Robert M Lee; Susan Kennedy; David Viskochil; Nicholas O Davidson
Journal:  Am J Hum Genet       Date:  2001-11-27       Impact factor: 11.025
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.